Lisa Paborsky
Chief Operating Officer at Ilios Therapeutics, Inc.
Lisa Paborsky active positions
| Companies | Position | Start | End |
|---|---|---|---|
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ilios Therapeutics, Inc.
 Ilios Therapeutics, Inc. Packaged SoftwareTechnology Services Ilios Therapeutics, Inc. develops a chemistry platform to generate therapeutics for neurodegenerative diseases. The American company was founded by Luca Giani and he has been the CEO since incorporation. | Chief Operating Officer | - | - |
Career history of Lisa Paborsky
Training of Lisa Paborsky
| State University of New York at Binghamton | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Health Technology |
Ilios Therapeutics, Inc.
Ilios Therapeutics, Inc. Packaged SoftwareTechnology Services Ilios Therapeutics, Inc. develops a chemistry platform to generate therapeutics for neurodegenerative diseases. The American company was founded by Luca Giani and he has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Lisa Paborsky
- Experience
